Promoted Content Promoted Content

X

Find Clinical Drug Development Pipelines & Deals | PipelineProspector

Loading...

All Data

Filters Filter refresh
×
FILTER DATA :
News Type filter
    Company filter
      Product Type filter
        Deal Size filter
          Upfront Payment filter
            refresh

            Product Type Full Screen

            Companies Full Screen

            Virtual Booth Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

            Contact the Supplier

            Lead Product(s): AEF0117

            Therapeutic Area: Psychiatry/Psychology Product Name: AEF0117

            Highest Development Status: Phase II Product Type: Small molecule

            Partner/Sponsor/Collaborator: Indivior

            Deal Size: $130.0 million Upfront Cash: $30.0 million

            Deal Type: Collaboration June 08, 2021

            Details:

            Indivior has entered into a strategic collaboration with Aelis Farma ("Aelis"), a private biotechnology company based in Bordeaux, France, that includes an exclusive option and license agreement (the "Agreement") for the global rights to AEF0117.